Buy Toficalm
Toficalm

1.78
Used to treat anxiety and emotional tension without causing sleepiness or dependency typical of other benzodiazepines.


Ingredient
Availability
In Stock
Delivery
Airmail (14-21 days) | EMS trackable (5-9 days)
Product is shipped in a fully discreet envelope with no content disclosure, including all required documentation inside

Product Sheet

Alternative/Local Brand
Grandaxin
Active Ingredient(s)
Tofisopam
Primary Category
Anxiety Relief
Therapeutic Class
Nervous system, Anxiolytics, Benzodiazepine derivatives
Pharmacological Class
2,3-Benzodiazepine
Indications
Nervousness, Anxiety and tension, Alcohol withdrawal symptoms, Apathy
Contraindications
First trimester of pregnancy, Breastfeeding, Respiratory failure, Sleep apnoea, Coma
Minor Side Effects
Nausea, Dry mouth, Constipation, Itching
Moderate Side Effects
Irritability, Sleep disturbance, Loss of appetite
Serious Side Effects
Confusion, Respiratory depression, Seizures, Skin rash
Dosage Forms
Tablet
Administration Route
Oral
Mechanism of Action
Tofisopam is an atypical benzodiazepine that focuses on anxiety relief without significant sedative or muscle-relaxing effects. It modulates brain activity to reduce emotional tension and autonomic nerve symptoms without causing drowsiness.
Prescription Status
Rx
Manufacturer
Sunrise Remedies
Patient Summary
Used to treat anxiety and emotional tension without causing sleepiness or dependency typical of other benzodiazepines.
Onset Time
1-2 hours
Duration
6-8 hours
Storage Instructions
Store below 25°C.
Drug Interactions
Anticonvulsants, Opioids, Alcohol
Age Restrictions
Not recommended for children
Pregnancy Use
Contraindicated in the first trimester; seek medical advice.
Alternative Drugs
Grandaxin, Tofisopam

What is Toficalm?

Toficalm is a brand-name medication that contains the active ingredient tofisopam. It is formulated as a 50 mg pill and belongs to the mental health therapeutic class, specifically as an anxiolytic agent. Tofisopam is a thienodiazepine derivative that exerts its effects on the central nervous system. In Hong Kong, the Drug Office of the Department of Health classifies Toficalm as a prescription-only product; it is not listed on the Hong Kong Pharmaceutical Registry as a locally approved medication, and it does not have approval from the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA). As such, its use should be guided by a qualified healthcare professional familiar with local regulations.

How Toficalm Works in the Body

Tofisopam acts primarily on the γ-aminobutyric acid type A (GABA-A) receptor complex, a key inhibitory neurotransmitter system in the brain. Unlike typical benzodiazepines, tofisopam binds to a distinct site on the receptor, producing anxiolytic (anxiety-reducing) effects with minimal sedation, muscle relaxation, or anticonvulsant activity.

  • Onset of action: Clinical observations suggest that symptom relief can begin within 30 minutes after oral ingestion.
  • Peak effect: Peak plasma concentrations are usually reached within 1-2 hours.
  • Duration: Therapeutic effects may last 6-8 hours, supporting once-daily dosing for many patients.

The drug is well absorbed from the gastrointestinal tract, undergoes hepatic metabolism (primarily via CYP3A4), and is excreted in the urine as inactive metabolites.

Conditions Treated by Toficalm

Tofisopam is primarily indicated for the short-term management of anxiety and tension-type symptoms in adult patients. In countries where it is authorized, the approved indication is typically:

  • Generalized anxiety disorder (GAD)
  • Situational or acute anxiety (e.g., stress-related episodes)

Because Toficalm lacks formal approval in Hong Kong, physicians may prescribe it off-label for these indications only after a careful risk-benefit assessment.

Off-Label and Investigational Applications

No high-quality randomized controlled trials or guideline-endorsed recommendations support off-label uses of tofisopam beyond anxiety management. Consequently, this article does not include an off-label section for Toficalm.

Who Should (and Should Not) Use Toficalm?

Ideal Patient Profile

  • Adults (≥ 18 years) experiencing mild to moderate anxiety symptoms
  • Individuals without significant hepatic or renal impairment
  • Patients not taking other CNS depressants that could compound sedation

Absolute Contraindications

  • Known hypersensitivity to tofisopam or any excipients in the pill
  • Severe acute narrow-angle glaucoma (risk of intra-ocular pressure increase)
  • Severe respiratory depression (e.g., uncontrolled chronic obstructive pulmonary disease)
  • Pregnancy (category D; potential risk to the fetus)
  • Breast-feeding (potential for infant exposure via milk)

Relative Contraindications

  • Moderate hepatic impairment (dose adjustment may be required)
  • Renal impairment (caution, monitor renal function)
  • Elderly patients (increased sensitivity to CNS effects)
  • Concomitant use of other anxiolytics, sedatives, or alcohol

When any of the above conditions are present, the prescriber must evaluate alternative therapies or adjust the treatment plan.

Safety Profile: Side Effects and Interactions

Common Side Effects

  • Drowsiness - often described as mild and transient
  • Fatigue - may affect daytime activities initially
  • Dizziness - especially when standing quickly
  • Headache - usually resolves within a few days
  • Dry mouth - can be mitigated with adequate hydration

These reactions are typically dose-related and improve with continued therapy or dose reduction.

Serious Adverse Events

  • Dependence and withdrawal - risk increases with prolonged high-dose use; abrupt discontinuation may cause rebound anxiety, insomnia, or irritability
  • Paradoxical reactions - rare cases of increased anxiety, agitation, or aggression
  • Severe skin reactions - such as Stevens-Johnson syndrome (extremely uncommon)

If any serious symptom emerges, medical attention should be sought promptly.

Drug Interactions

  • Major interactions: Concomitant use with other CNS depressants (e.g., benzodiazepines, barbiturates, opioids) can enhance sedation and respiratory depression.
  • Moderate interactions: Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin) may increase tofisopam plasma levels; dose adjustment or enhanced monitoring may be necessary.
  • Enzyme inducers (e.g., rifampicin, carbamazepine) can lower tofisopam concentrations, potentially reducing efficacy.

Patients should provide a complete medication list, including over-the-counter drugs and herbal supplements, before starting Toficalm.

Food and Lifestyle Interactions

  • Alcohol: Should be avoided, as it potentiates CNS depression and impairs judgment.
  • Driving/Machinery: Caution is advised until the individual knows how tofisopam affects their alertness.
  • Meals: The pill can be taken with or without food; taking it with food may reduce gastrointestinal upset.

How to Take Toficalm

  • Standard dosing: One 50 mg pill taken once daily, preferably in the morning or early afternoon to minimize nighttime drowsiness.
  • Titration: The prescribing clinician may increase the daily dose in 50 mg increments up to a maximum of 100 mg per day, but any adjustment must be based on individual response and tolerability.
  • Special populations:
  • Elderly: Start at 25 mg (half a tablet) once daily; increase slowly if needed.
  • Hepatic impairment: Consider a 25 % dose reduction and monitor liver enzymes.
  • Renal impairment: No specific dose change is required for mild to moderate dysfunction, but severe impairment warrants close observation.
  • Administration: Swallow the pill whole with a glass of water; do not chew, crush, or split unless instructed by a pharmacist.
  • Missed dose: If a dose is missed and the next scheduled dose is more than 6 hours away, take the missed tablet. Do not double-dose.
  • Overdose: Symptoms may include profound drowsiness, confusion, respiratory depression, and hypotension. Seek emergency medical care; treatment is supportive, and activated charcoal may be considered if presentation is early.
  • Discontinuation: Gradual tapering (e.g., reducing by 25 mg every 1-2 weeks) is recommended to avoid withdrawal phenomena, especially after prolonged therapy.

Monitoring and Follow-Up

  • Baseline assessment: Evaluate anxiety severity, liver function tests (ALT, AST), and renal function (creatinine) before initiation.
  • Follow-up visits: Typically scheduled after 2-4 weeks to assess efficacy, tolerability, and need for dose adjustment.
  • Laboratory monitoring: Repeat liver and renal panels every 3-6 months for long-term users.
  • Clinical signs: Promptly report increased anxiety, mood swings, or signs of dependence.

Storage and Handling

  • Store at room temperature (20 °C to 25 °C / 68 °F to 77 °F), away from excess moisture and direct sunlight.
  • Keep the medication out of reach of children and pets; use the original child-proof container.
  • Do not use the pill after the expiration date printed on the packaging.
  • Dispose of unused tablets according to local pharmaceutical waste guidelines or return them to a pharmacy take-back program.

Medication-Specific Glossary

GABA-A Receptor
A ligand-gated chloride channel in the central nervous system that mediates inhibitory neurotransmission; activation reduces neuronal excitability.
Anxiolytic
A class of drugs that alleviate anxiety without inducing significant sedation or muscle relaxation.
Dependence
A physiological state wherein abrupt cessation of the drug leads to withdrawal symptoms; may be physical, psychological, or both.
CYP3A4
A major enzyme in the liver responsible for metabolizing many medications; inhibitors can raise plasma levels of drugs metabolized by this pathway.

Medical Disclaimer

This article provides educational information about Toficalm and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.

Toficalm FAQ

Can I travel internationally with Toficalm?

Yes, but you should carry the original prescription label and keep the medication in its original container. Some countries may require a doctor’s note for controlled or prescription medicines, so verify entry requirements before departure.

Does Toficalm cause weight gain?

Weight changes are not a commonly reported effect of tofisopam. If you notice significant appetite changes, discuss them with your prescriber.

What inactive ingredients are in the Toficalm pill?

Typical excipients for oral tablets include lactose, microcrystalline cellulose, and magnesium stearate. The exact composition can be confirmed by consulting the product’s package insert.

Is Toficalm detectable in standard drug-testing panels?

Standard workplace or sports drug tests usually screen for classic benzodiazepines, not thienodiazepines like tofisopam. However, specialized tests can detect it if specifically requested.

Can Toficalm be taken with antihistamines?

Concurrent use with antihistamines that cause sedation (e.g., diphenhydramine) may increase drowsiness. Use caution and monitor your reaction.

What should I do if I miss a dose before a night shift?

If the missed dose is less than 6 hours before your next scheduled dose, skip the missed tablet and resume the regular schedule. Do not double the dose.

Are there any dietary restrictions while on Toficalm?

No specific foods must be avoided, but excessive alcohol consumption is contraindicated due to additive CNS depression.

How long does it take for Toficalm to be cleared from the body?

The elimination half-life of tofisopam averages 8-12 hours, meaning it generally requires 2-3 days to be mostly eliminated after discontinuation.

What is the typical cost of Toficalm in Hong Kong?

Pricing varies by pharmacy and whether a brand or generic version is supplied. For exact costs, consult local pharmacies; this article does not provide purchasing advice.

Categories